PureTech Health PLC (PRTC)
| Market Cap | 1.46B |
| Revenue (ttm) | 9.81M |
| Net Income (ttm) | 366.07M |
| Shares Out | 285.74M |
| EPS (ttm) | 14.40 |
| PE Ratio | 3.61 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $52.00 |
| Previous Close | $55.50 |
| Change ($) | -3.50 |
| Change (%) | -6.31% |
| Day's Open | 54.08 |
| Day's Range | 49.78 - 55.49 |
| Day's Volume | 987 |
| 52-Week Range | 38.50 - 60.96 |
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative.
BOSTON--(BUSINESS WIRE)--PureTech (Nasdaq: PRTC) initiated a global, Phase 2 trial of LYT-100 (deupirfenidone) in Long COVID respiratory complications and related sequelae.
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors
About PRTC
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for intractable cancers, lymphatic and gastrointestinal, central nervous system disorders, and inflammatory and immunological diseases in the United States. The company offers KarXT targeting muscarinic cholinergic receptors to treat schizophrenia and dementia-related psychosis, as well as pain; a superabsorbent hydrogel technology platform to treat excess weight and other chronic diseases related to the gastrointestinal pathways; a ... [Read more...]
| Industry Biotechnology | |
| CEO Daphne Zohar | Employees 300 |
| Stock Exchange NASDAQ | Ticker Symbol PRTC |
Analyst Forecasts
The average 12-month stock price forecast for PRTC is 66.33, which is an increase of 27.56% from the latest price.